Thinking beyond immunotherapy: implementing a multimodal care plan to facilitate extended survival in stage IV melanoma

Melanoma and Skin Cancer

Survival after cessation of immunotherapies in melanoma: A systematic review and meta-analysis

J Eur Acad Dermatol Venereol

Mayer KE, Warburton L, Zaremba A, Preis S, Foerster Y, Biedermann T, Persa OD

doi: 10.1111/jdv.20672

Melanoma and Skin Cancer

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Br J Dermatol

Nardin C, Cavalieri C, Lebbé C, Gérard E, Puyraveau M, Vergara R, Maubec E, Kramkimel N, Lesage C, Rouanet J, Bonniaud B, Puzenat E, Popescu D, Baroudjian B, Le Corre Y, Saiag P, Brunet Possenti F, Saint-Jean M, Montaudié H, Amini-Adle M, Belkaid S, Grange F, Mansard S, Béjar CL, Darras S, Pages C, Tournier E, Funck-Brentano E, Aubin F

doi: 10.1093/bjd/ljaf268

Melanoma and Skin Cancer

Survival impact of second primary cutaneous and non-cutaneous melanoma in melanoma survivors

J Eur Acad Dermatol Venereol

Xie J, Kiuru M, Pollock BH, Keegan THM

doi: 10.1111/jdv.70043

Melanoma and Skin Cancer

Psychological distress and unmet supportive care needs in melanoma-survivors and high-risk patients for melanoma: A Swiss cross-sectional study

Br J Dermatol

Sieborg J, Zwahlen D, Maul JT, Hædersdal M, Kjeldsen EW, Cerminara S, Goessinger EV, Egeberg A, Mangana J, Navarini A, Maul LV

doi: 10.1093/bjd/ljaf439

Melanoma and Skin Cancer

Immunotherapy for treatment of female genital tract melanoma: National Cancer Database analysis

Melanoma Res

Davidson SJ, Teoh DGK, Dudek AZ, Vogel RI

doi: 10.1097/CMR.0000000000001036

Further Publications Immunology

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

Acta Derm Venereol

Juan-Carpena G, Martínez Banaclocha N, Palazón Cabanes JC, Niveiro-de Jaime M, Betlloch Mas I, Blanes-Martínez M

doi: 10.2340/actadv.v105.42023

Melanoma and Skin Cancer

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

Br J Dermatol

Mistry K, Jeffrey P, Levell NJ, Kennedy O, Richardson K, Craig P, Bright C, Taylor S, Ragan J, Karponis D, Pethick J, Lavelle K, McRonald F, Hardy S, Vernon S, Lorigan P, Venables ZC

doi: 10.1093/bjd/ljaf351

Melanoma and Skin CancerFurther Publications Rheumatology

Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma

J Autoimmun

Tenstad HB, Ruhlmann CH, Möller S, Kjaer S, Bastholt L, Just SA, Lindegaard H

doi: 10.1016/j.jaut.2025.103400

Melanoma and Skin Cancer

Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024

J Eur Acad Dermatol Venereol

Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T

doi: 10.1111/jdv.70180

Related content

Survival after cessation of immunotherapies in melanoma: A systematic review and meta-analysis

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Survival impact of second primary cutaneous and non-cutaneous melanoma in melanoma survivors

Psychological distress and unmet supportive care needs in melanoma-survivors and high-risk patients for melanoma: A Swiss cross-sectional study

Immunotherapy for treatment of female genital tract melanoma: National Cancer Database analysis

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma

Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024